To determine mortality and factors that might predict outcome in severe community-acquired pneumococcal pneumonia treated by a standard protocol. Prospective, nonconcurrent study. Respiratory intensiv
Streptococcus pneumoniae is a major causative agent in community-acquired pneumonia and sepsis. Overwhelming lung inflammation during pneumococcal pneumonia may hamper lung function. Ibrutinib is an irreversible inhibitor of Brutons tyrosine kinase (Btk), a key signaling protein controlling the activation of various immune cells, including macrophages and neutrophils. The aim of this study was to determine whether ibrutinib treatment ameliorates acute lung inflammation during pneumococcal pneumonia. Mice were treated orally with ibrutinib and the effect on acute pulmonary inflammation elicited by the gram-positive bacterial cell wall component lipoteichoic acid (LTA) and during ceftriaxone-treated pneumococcal pneumonia was assessed. Treatment with ibrutinib prior to and after intranasal LTA instillation reduced alveolar macrophage activation, neutrophil influx, cytokine release and plasma leakage into the lung. Postponed treatment with ibrutinib supplementing antibiotic therapy during ongoing
Looking for pneumococcal pneumonia? Find out information about pneumococcal pneumonia. Consolidation of the lung caused by inflammatory exudation due to bacterial infection Explanation of pneumococcal pneumonia
We conducted a case-control study of adults with bacteremic pneumococcal pneumonia to identify factors associated with macrolide resistance. Study participants were identified through population-based surveillance in a 5-county region surrounding Philadelphia. Forty-three hospitals contributed 444 patients, who were interviewed by telephone regarding potential risk factors. In multivariable analyses, prior exposure to a macrolide antimicrobial agent (odds ratio [OR] 2.8), prior flu vaccination (OR 2.0), and Hispanic ethnicity (OR 4.1) were independently associated with an increased probability of macrolide resistance, and a history of stroke was independently associated with a decreased probability of macrolide resistance (OR 0.2). Fifty-five percent of patients with macrolide-resistant infections reported no antimicrobial drug exposure in the preceding 6 months. Among patients who reported taking antimicrobial agents in the 6 months preceding infection, failure to complete the course of prescribed
Background.: Detection of pneumococcus by lytA polymerase chain reaction (PCR) in blood had poor diagnostic accuracy for diagnosing pneumococcal pneumonia in children in 9 African and Asian sites. We assessed the value of blood lytA quantification in diagnosing pneumococcal pneumonia. Methods.: The Pneumonia Etiology Research for Child Health (PERCH) case-control study tested whole blood by PCR for pneumococcus in children aged 1-59 months hospitalized with signs of pneumonia and in age-frequency matched community controls. The distribution of load among PCR-positive participants was compared between microbiologically confirmed pneumococcal pneumonia (MCPP) cases, cases confirmed for nonpneumococcal pathogens, nonconfirmed cases, and controls. Receiver operating characteristic analyses determined the optimal threshold that distinguished MCPP cases from controls. Results.: Load was available for 290 of 291 cases with pneumococcal PCR detected in blood and 273 of 273 controls. Load was higher in MCPP
TY - JOUR. T1 - A meta-analysis of antimicrobial susceptibility profiles for pneumococcal pneumonia in sub-Saharan Africa. AU - Iroh Tam, Pui-Ying. AU - Sadoh, Ayebo E.. AU - Obaro, Stephen K.. PY - 2018/1/2. Y1 - 2018/1/2. N2 - Background: Pneumonia causes an enormous burden of childhood disease globally, particularly in low- and middle-income countries. Pneumococcus is the most common bacterial aetiology of pneumonia; however, antimicrobials are limited and may not adequately address the local epidemiology of the region. Aim: To undertake a review and meta-analysis of pneumonia studies in sub-Saharan Africa to evaluate antimicrobial susceptibility patterns in childhood pneumonia. Methods: Articles published in PubMed and Google between 2006 and 2016 which evaluated antimicrobial susceptibility profiles of pneumococcal pneumonia in children in sub-Saharan Africa were identified. The source of specimens, pathogens and antimicrobial susceptibility data were extracted. Pooled analysis of ...
Pneumococcal pneumonia is a leading cause of bacterial infection and death worldwide. Current diagnostic tests for detecting Streptococcus pneumoniae can be unreliable and can mislead clinical decision-making and treatment. To address this concern, we developed a preclinical model of pneumococcal pneumonia in nonhuman primates useful for identifying novel biomarkers, diagnostic tests, and therapies for human S. pneumoniae infection. Adult colony-bred baboons (n = 15) were infected with escalating doses of S. pneumoniae (Serotype 19A-7). We characterized the pathophysiological and serological profiles of healthy and infected animals over 7 days. Pneumonia was prospectively defined by the presence of three criteria: (1) change in white blood cell count, (2) isolation of S. pneumoniae from bronchoalveolar lavage fluid (BALF) or blood, and (3) concurrent signs/symptoms of infection. Animals given 10(9) CFU consistently met our definition and developed a phenotype of tachypnea, tachycardia, fever, ...
TY - JOUR. T1 - Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. AU - Weinberger, Daniel M.. AU - Simonsen, Lone. AU - Jordan, Richard. AU - Steiner, Claudia. AU - Miller, Mark. AU - Viboud, Cecile. PY - 2012/2. Y1 - 2012/2. N2 - BACKGROUND:Infection with influenza virus increases the risk for developing pneumococcal disease. The A/H1N1 influenza pandemic in autumn 2009 provided a unique opportunity to evaluate this relationship.METHODS:Using weekly age-, state-, and cause-specific hospitalizations from the US State Inpatient Databases of the Healthcare Cost and Utilization Project 2003-2009, we quantified the increase in pneumococcal pneumonia hospitalization rates above a seasonal baseline during the pandemic period.RESULTS:We found a significant increase in pneumococcal hospitalizations from late August to mid-December 2009, which corresponded to the timing of highest pandemic influenza activity. Individuals aged 5-19 years, who have a low ...
Asplenic individuals are susceptible for overwhelming infection with Streptococcus pneumoniae, carrying a high mortality. Although Toll-like receptor (TLR)-2 is considered the major receptor for Gram-positive bacteria in innate immunity, it does not play a major role in host defense against pneumococcal pneumonia. We wanted to investigate if in absence of an intact spleen as a first line of defense, the role of TLR2 during pneumococcal pneumonia becomes more significant, thereby explaining its insignificant role during infections in immune competent hosts. We intranasally infected splenectomized wildtype (WT), TLR2 knock-out (KO) and TLR2/4 double KO mice with either serotype 2 or 3 S. pneumoniae. There were no differences between asplenic WT and TLR2KO mice of bacterial loads in lung homogenates and blood, cytokine and chemokine levels in the lungs, and lung pathology scores. TLR2/4 double KO mice were not impaired in bacterial control as well, which indicates that besides the interaction between S.
Fingerprint Dive into the research topics of A new urinary antigen test score correlates with severity of pneumococcal pneumonia in children. Together they form a unique fingerprint. ...
TY - JOUR. T1 - Contribution of a urinary antigen assay (binax NOW) to the early diagnosis of pneumococcal pneumonia. AU - Bartlett, John. PY - 2004/1/1. Y1 - 2004/1/1. UR - http://www.scopus.com/inward/record.url?scp=85026149734&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=85026149734&partnerID=8YFLogxK. U2 - 10.1097/01.idc.0000130890.12611.f3. DO - 10.1097/01.idc.0000130890.12611.f3. M3 - Article. AN - SCOPUS:85026149734. VL - 12. JO - Infectious Diseases in Clinical Practice. JF - Infectious Diseases in Clinical Practice. SN - 1056-9103. IS - 4. ER - ...
Looking for acute lobar pneumonia? Find out information about acute lobar pneumonia. acute infection of one or both lungs that can be caused by a bacterium, usually Streptococcus pneumoniae , or by a virus, fungus, or other organism. Explanation of acute lobar pneumonia
What is Pneumonia?Pneumococcal disease is caused by bacteria that can spread from person to person through close contact. It can cause ear infections, and it can also lead to more serious infections of the:Lungs (pneumonia),Blood (bacteremia), andCovering of the brain and spinal cord (meningitis). Pneumococcal pneumonia is most common among adults. Pneumococcal meningitis can
Getting vaccinated can help protect you from pneumococcal pneumonia. Talk to your doctor or pharmacist about vaccination options during your next visit.
Background: We aimed to study if certain clinical and/or microbiological factors are associated with a high nasopharyngeal (NP) density of Streptococcus pneumoniae in pneumococcal pneumonia. In addition, we aimed to study if a high NP pneumococcal density could be useful to detect severe pneumococcal pneumonia.. Methods: Adult patients hospitalized for radiologically confirmed community-acquired pneumonia were included in a prospective study. NP aspirates were collected at admission and were subjected to quantitative PCR for pneumococcal DNA (Spn9802 DNA). Patients were considered to have pneumococcal etiology if S. pneumoniae was detected in blood culture and/ or culture of respiratory secretions and/or urinary antigen test.. Results: Of 166 included patients, 68 patients had pneumococcal DNA detected in NP aspirate. Pneumococcal etiology was noted in 57 patients (84%) with positive and 8 patients (8.2%) with negative test for pneumococcal DNA (p,0.0001). The median NP pneumococcal density of ...
To the Editor:. The mortality of pneumococcal pneumonia, and especially the number deaths that occur soon after presentation, remains unacceptably high [1]. In 1964, Austrian and Gold [2] observed that 60% of deaths in patients with invasive pneumococcal pneumonia (IPP) occurred within the first 5 days. Unfortunately, this does not appear to have changed over the subsequent five decades [3].. Different factors related to the mortality of pneumococcal disease have been described, including host factors such as age, comorbidities or immunosuppressive conditions [4], and organism-related factors such as serotype, bacterial load or viral co-infection [3, 5-7]. These factors have all been primarily identified to predict overall mortality, but information regarding the determinants of early mortality is scarce. It has been hypothesised that early deaths are more likely to be due to an inappropriate inflammatory response triggered by Streptococcus pneumoniae than to the micro-organism itself [8]. Thus, ...
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Background: Pneumococcal pneumonia causes parapneumonic effusion (PPE) in 40%-57%. Severity can be influenced by both host characteristics e.g. co-morbidity, age and vaccination status and, bacterial factors.. Aims and objectives: To study the relationship between host characteristics (age, co-morbidity and previous vaccination) and disease severity in adults admitted with pneumococcal pneumonia.. Methods: A cohort of 21 inpatients with pneumococcal pneumonia between December 2010 to January 2011 were retrospectively studied using electronic patient records, medical notes and the PACS system. Uncomplicated PPE (UPPE) was defined as pleural fluid pH ,7.2, complicated PPE (CPPE) as pH ,7.2 and empyema as visible purulent fluid.. Results: 21 patients were admitted with pneumococcal pneumonia, 8 male and 13 female, median age 48 years (range 18-76). 9 (43%) had no associated co-morbidity, of which 7 were ,65 years. 6/9 developed pleural effusion (1 UPPE, 4 CPPE and 1 empyema), 4 required chest ...
Of the one hundred and twenty-five (125) patients with pneumococcal pneumonia were studied. The mean age of the patients was 41.3years (± 16.84), and 69/125(55.2%) were males. Co-morbidities were observed in 63/125 (53.8%) of the patients. Resistance to commonly used antibiotics was observed. Overall in-hospital mortality was 9/117(7.8%). HIV (OR=2.081; 95%CI 1.651-3.237), age ≥65years (OR=5.947; 95%CI3.581-17.643), and CURB-65 score of ≥ 3 (OR=2.317; 95%CI1.734-4.719) were independent predictors of mortality.. Conclusion ...
Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates.s profile, publications, research topics, and co-authors
Pneumococcal pneumonia answers are found in the Diagnosaurus powered by Unbound Medicine. Available for iPhone, iPad, Android, and Web.
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Background: A recently licensed pneumococcal conjugate vaccine has been shown to be highly effective in the prevention of bacteremia in immunized children but the degree of protection against pneumonia has been difficult to determine. Methods: We sought to develop a model of Streptococcus pneumoniae pneumonia in Sprague-Dawley rats. We challenged three-week old Sprague-Dawley pups via intrapulmonary injection of S. pneumoniae serotypes 3 and 6B. Outcomes included bacteremia, mortality as well histologic sections of the lungs. Results: Pneumonia was reliably produced in animals receiving either 10 or 100 cfu of type 3 pneumococci, with 30% and 50% mortality respectively. Similarly, with type 6B, the likelihood of pneumonia increased with the inoculum, as did the mortality rate. Prophylactic administration of a preparation of high-titered anticapsular antibody prevented the development of type 3 pneumonia and death. Conclusion: We propose that this model may be useful for the evaluation of ...
to another; individuals with such a disease are required to avoid contact with other people. Pneumococci can also result in ear, brain, and other organs infections.. Individuals particularly at risk of progressing pneumococcal pneumonias include people with compromised immune systems and chronic diseases (for instance: sickle cell disease, Hodgkins Disease, malnutrition, myeloma, and lymphoma). Because antibody created in the persons spleen usually helps prevent pneumococcal infections, individuals with nonfunctioning spleen or with removed spleen are also at higher risk.. Pneumococcal Pneumonias can also occur after chronic bronchitis or influenza virus, damaging the respiratory tracts lining. For individuals over the age two, a very effective pneumococcal vaccines are available. Such vaccine protects against the most common Pneumococci strain and lowers the chances of progressing bacteremia and Pneumococcal Pneumonia by 80% and the dying chances of those by 40%.. The vaccine is recommended ...
0.001). When the analysis was limited to children 2 years of age, assay of IgG ALS to pneumococcal proteins was unable to discriminate between children with pneumococcal pneumonia and non-pneumococcal pneumonia (AUROCC 0.67, 95% CI 0.47C0.88). This method detected spontaneous secretion of IgG to pneumococcal protein antigens from cultured PBMCs. However, when stratified by age group, RX-3117 assay of IgG in ALS to pneumococcal proteins showed limited utility RX-3117 as a test to discriminate between pneumococcal and non-pneumococcal pneumonia in children. to determine whole blood pneumococcal load (Deloria Knoll et al., 2017), and density of nasopharyngeal (NP) colonization with (Baggett et al., 2017), exhibited only moderate ability to discriminate between pneumococcal pneumonia and age-matched community children. An alternative approach to the diagnosis of pneumococcal pneumonia is usually to assess the immune response to the pathogen. Unfortunately, serological assays have limited specificity ...
Immunization with Prevnar 13 can play an important role in helping to reduce the incidence and burden of vaccine-type pneumococcal community-acquired pneumonia and invasive pneumococcal disease among adults 65 years of age or older, said Luis Jodar, Ph.D., vice president, Vaccines, Global Medicines Development Group and Scientific Affairs. This additional ACIP meeting recognizes the importance of implementing an adult recommendation for Prevnar 13 in advance of the U.S. influenza season, the time of year when this population is most likely to be considering vaccination.. Pneumococcal pneumonia is the most common type of community-acquired bacterial pneumonia in the United States. About 900,000 Americans get pneumococcal pneumonia each year, nearly half of whom end up in the hospital. Among adults 50 years of age and older, there are approximately 440,000 cases of pneumococcal pneumonia each year in the United States, with approximately 25,000 pneumococcal disease-related deaths ...
Experimental pneumonia due to Friedländers bacillus was produced in white rats by the intrabronchial inoculation of the bacilli suspended in mucin. The pneumonia was lobar in type, was almost uniformly fatal, and simulated the acute form of the natural disease in human beings.. The pathogenesis of the pneumonic lesion was studied by examination of microscopic sections of the lungs of animals killed at frequent intervals during the course of the infection. The histologic characteristics of the various stages of the pneumonia were essentially the same as those previously described in experimental pneumococcal (Type I) pneumonia except for the following differences: (1) In isolated areas of the lung in Friedländers pneumonia many more bacteria were encountered in the alveoli than were ever noted in experimental pneumococcal pneumonia. (2) Abscess formation was common in the late stages of Friedländers infection, whereas it was not noted in the pneumococcal lesion. (3) Organization of the ...
Classically, the disease has four stages: Congestion in the first 24 hours: This stage is characterized histologically by vascular engorgement, intra-alveolar fluid, small numbers of neutrophils, often numerous bacteria.Grossly, the lung is heavy and hyperemic. In late 2018, coding guidance (and indexing) was published instructing coders to report the diagnosis of lobar pneumonia to J18.1 (Lobar pneumonia) when the pneumonia was specified to a particular lobe(s). The Infectious Diseases Society of America (IDSA) has published guidelines for the treatment of community-acquired pneumonia (CAP). 45. This review discusses diagnostic methods, empiric treatment, and infection prevention strategies for … As our understanding of this common infection grows, collaborative efforts among researchers and clinical societies provide new literature and updated guidelines informing its management. Upper-lobar focal pneumonia causes severe chills and headaches, fever, chest pain. The symptoms and signs of ...
1. Pneumococci of Type I and Type II are responsible for the majority of the cases of lobar pneumonia.. 2. Among the pneumococci found in the mouths of healthy individuals Type IV predominates, Type III is frequent, and atypical organisms of Type II are occasionally found.. 3. Healthy persons intimately associated with cases of lobar pneumonia may harbor in their mouth secretions the highly parasitic pneumococcus of Types I and II.. 4. Occasionally a carrier of Type I or Type II pneumococcus is encountered in whom it is impossible to trace any contact with an infected patient.. 5. From the dust of homes where cases of pneumonia due to Types I and II have occurred, pneumococci of the same type may be recovered.. ...
Streptococcus pneumoniae serotype 3, isolated from a penicillin-allergic patient and initially susceptible to fluoroquinolones, macrolides, lincosamides, quinupristin-dalfopristin, and telithromycin, became resistant to all these drugs during treatment. Mutations in the parC and gyrA and in the 23S rRNA and the ribosomal protein L22 genes were detected in the resistant isolates.
Although most children, young adults and pregnant women are at highest risk for H1N1 swine flu infections, older adults with H1N1 infections are more likely to develop pneumonia with pneumococcus bacteria. The Centers for Disease Control has urged physicians to make sure their adult patients are vaccinated with pneumococcal saccharide (with 23 pneumococcal components) vaccine (e.g.…
Dr. Gallant responded: Pneumoniae + coccus. The official name of the organism is |a href=/topics/streptococcus track_data={
Sigma-Aldrich offers abstracts and full-text articles by [Carolin Hartmann, Ann-Kathrin Behrendt, Stefanie Henken, Florian Wölbeling, Ulrich A Maus, Gesine Hansen].
A study has been made of the occurrence of the macrophage reaction in the pulmonary lesions of dogs sacrificed during the course of experimentally induced pneumococcus lobar pneumonia or dying as a result of the infection. This characteristic transformation of the fixed tissue cells of the lung was found as a constant accompaniment of recovery. It was also present in varying degrees in the great majority of fatal instances provided the animal lived more than 40 hours. In general the longer the animal survived, the more pronounced the macrophage reaction observed in the lung lesions at autopsy. The numbers of pneumococci in the lesions diminished progressively with the evolution of the cellular change which terminated in resolution of the pneumonic exudate. Some dogs surviving for 4 days or more showed practically complete clearing of the pulmonary lesions but succumbed with an overwhelming bacteremia or empyema or both. On the other hand, several animals dying with a sterile blood, exhibited ...
Pneumonia is a serious (and potentially fatal) infection of the lungs caused by a bacterial, viral or fungal infection, including influenza. One pathogen that can cause pneumonia is a bacteria called Streptococcus pneumoniae. Infection with this bacteria causes pneumococcal disease, and pneumococcal pneumonia is the most common serious complication from infection.. The pneumococcal vaccine is recommended for all adults ages 65 and older. In addition, the CDC also recommends the vaccine for adults ages 19 to 64 who smoke cigarettes, have conditions that weaken the immune system, have cochlear impacts or are living with a chronic illness of the heart, lungs, liver or kidneys.. Often only one dose is needed. However, the CDC recommends one or two additional doses for those with certain chronic medical conditions, so talk with your doctor.. ...
Although recent reports of successes in the diagnosis and treatment of the pneumonias, according to specific criteria, have been impressive, it can hardly be said that the medical world is committed to the procedures. There are several valid reasons why this is true. While there have been excellent results reported by reliable observers in the treatment of the acute pneumonias with specific serum, the technical difficulties involved in accurate typing, as well as the expense incurred in the use of curative serum, are the major objections raised, and the ones which have caused clinicians to approach the subject with hesitation. ...
Pneumonia Vaccine for senior citizens. Pneumonia is an infective disease which presents in the elderly with very different symptoms like weakness, dizziness, falls and altered sensorium. This results in to delayed diagnosis and can result into a life threatening illness. Now a single dose Vaccine to prevent pneumococcal pneumonia in the elderly is available and is advised to persons aged 65 and above. Aastha Foundation will provide free vaccines to elderly citizens in Aurangabad this #DaanUtsav.. ...
Ask the Doc looks at vaccines for people living with HIV/AIDS, including the recent meningitis vaccines, for pneumococcal pneumonia, for HPV, or even just a yearly flu shot.
In children, there is a broad array of risk factors and causes as compared to adults (see Balance Blueprint 16. There are five types of quantity analyzers commonly used on proteomics scrutinize and they veer in their physical principles and analytical show (learn ensure Liu et al. These diseases include: Arthritic arthritis; Systemic TB erythematosus (commonly titled lupus); and Ankylosing spondylitis (spinal arthritis) buy 2 mg estrace mastercard pregnancy zyrtec. The minister to is caring instead of orthopedic children who are in the postoperative spell following spinal fusion. Other symptoms seen during the sure of the sickness cover: В· Adequately symmetric flaccid affection or paralysis В· Ataxia В· Sensory disturbances Physical Inquiry and Laboratory and Diagnostic Tests Woman check-up findings may tabulate decreased or wanting tendon reflexes. Influence of neutropenia on the row of serotype 8 pneumococcal pneumonia in mice discount azithromycin 250mg on line bacteria life cycle. ...
O, Sharif; R, Gawish; JM, Warszawska; R, Martins; K, Lakovits et al. [..] (2014) The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia. PLoS Pathogens (10(6)), S. e1004167 ...
In another era, pneumococcal pneumonia was called the old mans friend because it provided a quick, painless death in frail elderly persons. In 1977, a 14-valent polysaccharide pneumococcal vaccine was licensed and recommended for adults , 65 years of age because of its low toxicity, reasonable immunogenicity, and modest cost. Since then, doubt has persisted about the mortality benefit of this vaccine (now ...
TY - JOUR. T1 - Detection of pneumococcal DNA in blood by polymerase chain reaction for diagnosing pneumococcal pneumonia in young children from low- and middle-income countries. AU - PERCH Study Group. AU - Morpeth, Susan C.. AU - Knoll, Maria Deloria. AU - Scott, J. Anthony G.. AU - Park, Daniel E.. AU - Watson, Nora L.. AU - Baggett, Henry C.. AU - Brooks, W Abdullah. AU - Feikin, Daniel. AU - Hammitt, Laura L. AU - Howie, Stephen R.C.. AU - Kotloff, Karen L.. AU - Levine, Orin S.. AU - Madhi, Shabir A.. AU - OBrien, Katherine L. AU - Thea, Donald M.. AU - Adrian, Peter V.. AU - Ahmed, Dilruba. AU - Antonio, Martin. AU - Bunthi, Charatdao. AU - Deluca, Andrea. AU - Driscoll, Amanda J.. AU - Githua, Louis Peter. AU - Higdon, Melissa. AU - Kahn, Geoff. AU - Karani, Angela. AU - Karron, Ruth A. AU - Kwenda, Geoffrey. AU - Makprasert, Sirirat. AU - Mazumder, Razib. AU - Moore, David P.. AU - Mwansa, James. AU - Nyongesa, Sammy. AU - Prosperi, Christine. AU - Sow, Samba O.. AU - Tamboura, ...
Innate immune responses play important roles in host defense against S. pneumoniae infection. In this study, we elucidated the mechanism of caspase-1 activation in macrophages infected with PLY-producing S. pneumoniae. We found that ASC inflammasomes, including both AIM2 and NLRP3, but not TLR4, are indispensable for inducing the activation of caspase-1 and the maturation and secretion of IL-1β and IL-18 and for pyroptosis. In addition, our results clearly demonstrate the essential requirement for ASC for the secretion of IL-1β and IL-18 into the BALF in a mouse model of pneumococcal pneumonia. We also showed that the absence of ASC results in a significant increase in the susceptibility to S. pneumoniae infection in vivo. Thus, this study revealed a novel role of ASC inflammasomes in mediating host resistance to pneumococcal pneumonia, most likely through the induction of the protective cytokines IL-1β and IL-18.. In contrast to our results, PLY has been shown to inhibit the production of ...
To the Editor-The recent report on co-infection of influenza B and Streptococcus by Lam et al1 is very interesting. They reported four cases infected with influenza B and streptococci that gave rise to severe pneumonia and mentioned that this is the second case report of severe invasive pneumococcal pneumonia secondary to influenza B infection.1 Indeed, both influenza B and Streptococcus infections are important infectious diseases that are encountered worldwide. In fact, there are more than two previous publications reporting the concurrent infection of influenza B and Streptococcus.2 3 In the report by Aebi et al,2 three cases were document and additional four cases were presented in the report by Scaber et al.3 Hence, the claim by Lam et al1 should not be correct. Nevertheless, in all reports, the clinical features of the pneumonia were serious and sometimes fatal. As Lam et al1 suggested, physicians should increase awareness of possible concurrent infection in the present era of ...
Pneumococcal pneumonia is one of these diseases. Your risk of being hospitalized after getting pneumococcal pneumonia at 65 years or older is thirteen times greater than adults who are younger than 50 years old!. You may feel like you were able to bounce back quicker from illnesses when you were younger, but youre not as resilient at 50, 60 or 70, no matter how fit you think you are. It would depress me if I was too weak to work, not to mention keep up with my 4 ½-year-old grandson, who doesnt stop moving, except when hes asleep. And, who would walk Rigby if I was laid up in bed! I am one of the 46.2 million Americans over the age of 65, and thankfully, we Baby Boomers are a vibrant group. A close 60-something friend goes white water rafting and can hike 16 miles in Grand Teton National Park. I know not all boomers our age are as adventurous as my friend, but were booming by exploring new passions and activities, and we dont want anything to keep us down. Pneumococcal pneumonia obviously ...
Lobar pneumonia is a form of pneumonia that affects a large and continuous area of the lobe of a lung. It is one of the two anatomic classifications of pneumonia (the other being bronchopneumonia). Lobar pneumonia usually has an acute progression. Classically, the disease has four stages: Congestion in the first 24 hours: This stage is characterized histologically by vascular engorgement, intra-alveolar fluid, small numbers of neutrophils, often numerous bacteria. Grossly, the lung is heavy and hyperemic Red hepatization or consolidation: Vascular congestion persists, with extravasation of red cells into alveolar spaces, along with increased numbers of neutrophils and fibrin. The filling of airspaces by the exudate leads to a gross appearance of solidification, or consolidation, of the alveolar parenchyma. This appearance has been likened to that of the liver, hence the term hepatization. Grey hepatization: Red cells disintegrate, with persistence of the neutrophils and fibrin. The alveoli ...
S. pneumoniae can be found colonizing the oropharynx of 5-10% of healthy adults and up to 40-60% of toddlers and young children in day care centers. Invasive disease (defined by the isolation of S. pneumoniae from normally sterile sites such as blood, CSF) occurs worldwide at a rate of about 15 per 100,000 persons per year, but a 10 fold higher incidence has been noted in African Americans, Native Americans, and Australian Aborigines. Pneumococcus may be transmitted from individual to individual when there is extensive and close contact, such as in military camps, prisons, shelters, nursing homes, and day care centers. However, isolating individual patients with infection is not routinely recommended ...
Remember the phrase Round and round she goes, and where she stops nobody knows? Well, thats how I feel when considering coding direction related to lobar pneumonia. It seems we are on a merry-go-round and just when we think it is safe to get off, it picks up speed and keeps going. So lets review coding of lobar pneumonia discussed in the first blog which was posted on this topic last March and then examine the subsequent advice change.. (Original blog post). Change - a concept with which coding professionals are all too familiar. This In the kNOW delves into an example of why it is so vital to constantly update a coding professionals knowledge base by examining the diagnosis of lobar pneumonia and reviewing relevant Coding Clinics related to that diagnosis. Lobar pneumonia is type of pneumonia that affects an entire pulmonary lobe or multiple lobes of the lung. In the vast majority of cases, lobar pneumonia is caused by Streptococcus pneumonia. As such, initial guidance from Coding Clinic ...
Health Canada Approves Expanded Indication for Prevnar 13Kirkland, Quebec - August 5, 2015 - Prevnar® 13 (pneumococcal 13-valent conjugate vaccine) has received Health Canadas approval for active immunization of adults 18 years of age and older for the prevention of pneumonia caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.[1]
Cases reported • Pneumonia; Experimental Lung Inflammation; Lobar Pneumonia; Lung Inflammation; Pneumonia, Lobar; Pneumonitis; Pulmonary Inflammation. On-line free medical diagnosis assistant. Ranked list of possible diseases from either several symptoms or a full patient history. A similarity measure between symptoms and diseases is provided.
Lobar pneumonia (also known as non-segmental pneumonia or focal non-segmental pneumonia 7) is a radiological pattern associated with homogenous, fibrinosupparative consolidation of one or more lobes of a lung in response to bacterial pneumonia. ...
As residents age, their health needs become more complex and many find themselves coping with chronic conditions such as heart disease, lung disease, and diabetes. For all residents in a long-term care facility, but for residents with chronic conditions especially, vaccines are an important part of decreasing the risk for further health complications. While it is the job of nurses and CNAs to administer vaccines, its up to the billers to ensure your facility is being reimbursed appropriately for these common services.
The acute phase response is an evolutionarily conserved reaction in which physiological stress triggers the liver to remodel the blood proteome. Although thought to be involved in immune defense, the net biological effect of the acute phase response remains unknown. As the acute phase response is stimulated by diverse cytokines that activate either NF-κB or STAT3, we hypothesized that it could be eliminated by hepatocyte-specific interruption of both transcription factors. Here, we report that the elimination in mice of both NF-κB p65 (RelA) and STAT3, but neither alone, abrogated all acute phase responses measured. The failure to respond was consistent across multiple different infectious, inflammatory, and noxious stimuli, including pneumococcal pneumonia. When the effects of infection were analyzed in detail, pneumococcal pneumonia was found to alter the expression of over a thousand transcripts in the liver. This outcome was inhibited by the combined loss of RelA and STAT3. Moreover, this ...
PubMed Central Canada (PMC Canada) provides free access to a stable and permanent online digital archive of full-text, peer-reviewed health and life sciences research publications. It builds on PubMed Central (PMC), the U.S. National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature and is a member of the broader PMC International (PMCI) network of e-repositories.
25 patients with lobar pneumonia were studied. 10 patients were jaundiced; the remaining 15 formed a control group. 2 of the jaundiced patients and 1 of the control group were found to be G-6-PD deficient. G-6-PD deficiency does not seem to playa role in the jaundice associated with pneumonia.
False-colour chest X-ray showing lobar pneumonia in the lower lobe of a patients right lung, which appears as the pale blue area of the lower lung at left of image. The disease is caused by certain strains of the bacterium Streptococcus pneumoniae. Alveoli (the air sacs of the lung) become blocked with pus, forcing air out and causing the lung to become solidified. Here, colouring highlights the reduction in effective size of healthy lung on the left of image, compared to the normal right-side lung. - Stock Image M240/0085
Despite good access to antibiotics, Streptococcus pneumoniae is still a significant cause of illness and death worldwide. S. pneumoniae causes several acute, invasive and noninvasive clinical infections; it is one of the leading causative agents in COPD exacerbations; and it is the most frequently detected pathogen responsible for community- acquired pneumonia (CAP). Pneumococcal pneumonia is accompanied by bacteraemia (bacteria in the blood) in 10-30% of cases.. S. pneumoniae is gaining resistance to the in vitro activity of several antimicrobial agents and, even if questions remain regarding the clinical impact of this phenomenon, increasing numbers of reports indicate that antibiotic resistance can lead to more treatment failures, if not higher mortality.. Reported incidence rates of invasive pneumococcal disease in European and US studies indicate an overall incidence of 11-23.2 per 100 000 people, rising to 16.2-59.7 per 100 000 in adults over 65 years of age. The studies in question were ...
폐렴구균(Streptococcus pneumoniae)는 폐렴(pneumonia). 패혈증(bacteremia), 뇌수막염(meningitis), 중이염(otitis media), 및 부비강염(sinusitis) 등의 질환을 유발하는 중요한 병원균으로, 항생제 치료에도 불구하고 폐렴구균에 의한 감염성 질환의 발병률과 치사률이 전세계적으로 매우 높게 나타나고 있다. 본 연구는 1996년부터 1999년까지 서울 소재 대학병원에 내원한 환자로부터 수집한 폐렴구균 142주를 대상으로 하였다. 국내의 임상 분리 폐렴구균의 현황을 확인하기 위하여 혈청형 분석 및 항생제 감수성 조사를 실시하였고, 국내 유행 혈청형으로 확인된 혈청형 19F와 23F 균주들간의 유전적 상관성을 조사하였다. 또한, 폐렴구균의 표면 단백 항원인 37 kDa의 pneumococcal surface adhesin A (PsaA)의 면역원성 분석을 통해 폐렴구균성 감염질환에 대한 백신 후보 또는 진단 지표로서의 사용 ...
Children younger than 5 and adults 65 and older should get vaccinated against pneumococcal pneumonia, a common form of bacterial pneumonia. The pneumococcal vaccine is also recommended for all children and adults who are at increased risk of pneumococcal disease due to other health conditions. There are 2 types of pneumococcal vaccine. Talk to your healthcare provider to find out if one of them is right for you. ...
Pneumonia is a common lung infection caused by bacteria, a virus or fungi. Most healthy people recover from pneumonia in one to three weeks, but pneumonia can be life-threatening. The good news is that pneumonia can be prevented-by getting an annual flu shot, frequently washing your hands, and for people at high risk, getting a vaccine for pneumococcal pneumonia.
h. Bronchial pneumonia begins in the bronchi, spread into the surrounding tissues toward the alveoli. It appears as a secondary infection and no fibrin deposits. This is common in elderly and debilitated patients and is sometimes called the oldmans friend, and painful death occurs. They are transmitted by respiratory droplets and by carriers. The onset of pneumococcal pneumonia is sudden after a few days of mild upper respiratory symptoms. The infected person suffers violent chills and high fever. Chest pain, cough and sputum containing blood, mucus follows. Fever may end 5-10 days after onset when untreated, or within 24 hours after antibiotics are given. Penicillin is the drug of choice. The patient after recovery, immunity exists for a few months only against particular serotype, so infection developed by other serotypes. Prevnar, an anti - S. pneumoniae vaccine introduced for young children to prevent pneumonia and ear infections. ...
Clement CG, Evans SE, Evans CM, Hawke D, Kobayashi R, Reynolds PR, Moghaddam SJ, Scott BL, Melicoff E, Adachi R, Dickey BF, Tuvim MJ. Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am J Respir Crit Care Med. 2008 Jun 15; 177(12):1322-30 ...
Intern Diane Goede presenting a case of Pneumococcal Pneumonia using the SOAP format. Bedside Checklist (presented by the bedside nurse).. Upon completion of SOAP in front of the patient the intern, nurse, team resident or attending should go through the bedside checklist using the mneumonic TEMP. Fulfilling these needs is likely to improve patient well being and satisfaction with his/her care. T - Tubes - IV lines, foley catheter, feeding tube: are these lines necessary; can they be discontinued?. E - Exercise: Can your patient get out of bed? Is physical therapy required? Eating: Is the diet acceptable to your patient? Does it fit with their chronic illness? Elimination: Bowel movements Sleep - Is your patient getting enough sleep? if not why not?. M - Monitoring: Does your patient require Q4H or Q8H vital signs? Can vital signs be held when you patient is sleeping? Does your patient continue to require telemetry? Does your patient require daily blood drawing?. P - Pain: Is your patients pain ...
Community-acquired pneumonia (CAP) is still a pediatric common illness that afflicts children troughout the world. Streptococcus pneumoniae is one of the most common and virulent pathogens so an early diagnosis is very important to do a right treatment. Our study has evaluated the role of symptoms, chest radiograph and microbiological test to determine a S.pneumoniae pneumonia.We conducted a prospective study from January to September 2005 including 44 children (1month-15 years old) admitted to the Padova Pediatric ED suffering from pneumonia confirmed with a chest radiograph. From the obtained results the nasopharyngeal aspirate culture and the pneumococcal urine antigen are complementary and we can make a right diagnosis if we associate this test with symptoms and laboratory test ...
Free, official coding info for 2018 ICD-10-CM J18.1 - includes detailed rules, notes, synonyms, ICD-9-CM conversion, index and annotation crosswalks, DRG grouping and more.
double pneumonia definition: Pneumonia influencing both lung area.; Pneumonia influencing both lung area.; lobar pneumonia concerning both lung area
CHAPTER V. PNEUMONIA. THE term pneumonia, while generally understood to refer to the lobar disease particularly designated as croupous pneumonia, is a vague one, really comprehend- ing a variety of inflammatory conditions of the lung quite dissimilar in character. This being true, no one should be surprised to find that a single organism cannot be described as specific for all. Indeed, pneumonia must be considered as a group of diseases, and the various microbes found associated with it must be described suc- cessively in connection with the peculiar phase of the disease in which they occur. i. Lobar or Croupous Pneumonia. The bacterium, which can be demonstrated in at least 75 per cent of the cases of lobar pneumonia, which is now almost uni- versally accepted as the cause of the disease, and about whose specificity very few doubts can be raised, is the pneumococcus of Prankel and Weichselbaum. Priority of discovery in the case of the pneumococcus seems to be in favor of Sternberg, who as ...
You may have heard reports this week that the number of new cases of H1N1 flu has leveled off. Thats good news, though it may bring a false sense of security.